Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Hart, Robert G., Pearce, Lesly A., Aguilar, Maria I.·2007·Annals of Internal Medicine

DOI 10.7326/0003-4819-146-12-200706190-00007

Cited by (1,005)

Items 401–500 of 1,005

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation ( STUDY‐AF )
Mintu P. Turakhia, Aditya J. Ullal, Donald D. Hoang, Claire T. Than, Jared D. Miller, Karen J. Friday, Marco Valentin Perez, James V. Freeman, Paul J. Wang, Paul A. Heidenreich · 2015 · Clinical Cardiology
Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The “Bayes' Syndrome-HF” study
Luis Alberto Escobar‐Robledo, Antoni Bayés‐Genís, Josep Lupón, Adrian M Baranchuk, Pedro Moliner, Manuel Martínez‐Sellés, Elisabet Zamora, Marta de Antonio, Mar Domingo, Germán Cediel et al. · 2018 · International Journal of Cardiology
Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation
Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, Gregory Y.H. Lip · 2017 · JAMA Internal Medicine
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug
Santoro, Gennaro, Meucci, Francesco, Stolcova, Miroslava, Rezzaghi, Marco, Mori, Fabio, Palmieri, Cataldo, Paradossi, Umberto, Pastormerlo, Luigi Emilio, Rosso, Gabriele, Berti, Sergio · 2016 · EuroIntervention
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, Jens Cosedis, Lin, Yenn-Jiang, de Oliveira Figueiredo, Marcio Jansen, Sepehri Shamloo, Alireza, Alfie, Alberto, Boveda, Serge, Dagres, Nikolaos, Di Toro, Dario, Eckhardt, Lee L, Ellenbogen, Kenneth et al. · 2020 · EP Europace
Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
M. Lamberts, G. Lip, M. L. Hansen, J. Lindhardsen, J. Olesen, Jakob Raunsø, Annemarie Olsen, P. Andersen, T. Gerds, E. Fosbøl et al. · 2014 · Annals of Internal Medicine
Risk Factors for Thrombus Formation on the Amplatzer Cardiac Plug After Left Atrial Appendage Occlusion
Bjoern Plicht, Thomas F. M. Konorza, Philipp Kahlert, Fadi Al‐Rashid, Hagen Kälsch, Rolf Alexander Jánosi, Thomas Buck, Hagen S. Bachmann, Winfried Siffert, Gerd Heusch et al. · 2013 · JACC: Cardiovascular Interventions
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
Davide Capodanno, Piera Capranzano, Giuseppe Giacchi, Valeria Ilia Calvi, Corrado Tamburino · 2012 · International Journal of Cardiology
Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF
Vivek Yerrapu Reddy, Ronald L. Akehurst, Shannon O. Armstrong, Stacey L. Amorosi, Stephen M. Beard, David R. Holmes · 2015 · Journal of the American College of Cardiology
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
Robert G. Hart, Mukul Sharma, Hardi Mundl, Ashkan Shoamanesh, Scott Eric Kasner, Scott D. Berkowitz, Guillaume Paré, Bodo Kirsch, Janice Pogue, Calin Pater et al. · 2016 · European Stroke Journal
Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands
Maartje S. Jacobs, Femke Kaasenbrood, Maarten Jacobus Postma, Marinus van Hulst, Robert G. Tieleman · 2016 · EP Europace
Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa
Kenneth Alan Bauer · 2011 · Journal of Thrombosis and Haemostasis
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Endalkachew Admassie Alamneh, Leanne Chalmers, Lre Bereznicki · 2016 · American Journal of Cardiovascular Drugs
Detection of atrial fibrillation episodes using a wristband device
Valentina Corino, Rita Laureanti, Lorenzo Ferranti, Giorgio Scarpini, Federico Lombardi, Luca Tommaso Mainardi · 2017 · Physiological Measurement
Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records
Olivia L. Hulme, Shaan S. Khurshid, Lu-Chen C Weng, Christopher D. Anderson, Elizabeth Y. Wang, Jeffrey M. Ashburner, Darae Ko, David D. McManus, Emelia J. Benjamin, Patrick T. Ellinor et al. · 2019 · JACC. Clinical electrophysiology
Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines
Christopher C. Cheung, Stanley Nattel, Laurent Macle, Jason G. Andrade · 2021 · Canadian Journal of Cardiology
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis
Maxim Grymonprez, Cynthia Simoens, Stéphane Steurbaut, Tine LM de Backer, Lies Lahousse · 2021 · EP Europace
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
Nikolaos Dagres, Tze‐Fan Chao, Guilherme Fenelon, Luis Aguinaga, Daniel A. Benhayon, Emelia J. Benjamin, Thomas Jared Bunch, Lin Y. Chen, Shih‐Ann Chen, Francisco Darrieux et al. · 2018 · EP Europace
Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
Julia Hippisley‐Cox, Carol A. C. Coupland · 2014 · BMJ
Atrial fibrillation patients do not benefit from acetylsalicylic acid
Sara Själander, Anders Själander, Peter J. Svensson, Leif Friberg · 2013 · EP Europace
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
Yi‐Hsin Chan, Tze‐Fan Chao, Shao‐Wei Chen, Hsin‐Fu Lee, Yung‐Hsin Yeh, Ya-Chi Huang, Shang‐Hung Chang, Chi-Tai Kuo, Gregory Y.H. Lip, Shih‐Ann Chen · 2020 · Heart Rhythm
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment
Emilia Antonucci, Elisa Grifoni, Rosanna Abbate, Gian Franco Gensini, Domenico Prisco, Daniela Poli · 2009 · Thrombosis and Haemostasis
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
Flaker, Greg C., Eikelboom, John W., Shestakovska, Olga, Connolly, Stuart J., Kaatz, Scott, Budaj, Andrzej, Husted, Steen, Yusuf, Salim, Lip, Gregory Y. H., Hart, Robert G. · 2012 · Stroke
Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000–2009
Anna Scowcroft, Sally Lee, Jonathan Mant · 2012 · Heart
Secondary stroke prevention in people with atrial fibrillation: treatments and trials
David Julian Seiffge, Virginia Cancelloni, Lorenz Räber, Maurizio Paciaroni, Andreas Metzner, Paulus F. Kirchhof, Urs Fischer, David John Werring, Ashkan Shoamanesh, Valeria Caso · 2024 · The Lancet Neurology
CHA 2 DS 2 -VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke
Tae‐Hoon Kim, Pil‐Sung Yang, Daehoon Kim, Hee Tae Yu, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Gregory Y.H. Lip · 2017 · Stroke
Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study
Karl Georg Hæusler, Paulus F. Kirchhof, Claudia Kunze, Serdar Tütüncü, Cornelia Fießler, Carolin Malsch, Manuel C. Olma, Muhammad Jawad Ul Qamar, Michael Krämer, Rolf Wachter et al. · 2021 · The Lancet Neurology
Atrial fibrillation: stroke prevention
Tze‐Fan Chao, Tatjana Potpara, Gregory Y.H. Lip · 2024 · The Lancet Regional Health - Europe
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
Gregory Y.H. Lip · 2011 · Journal of Thrombosis and Haemostasis
Heart Failure in Patients with Atrial Fibrillation in Europe: A Report from the Eurobservational Research Programme Pilot Survey on Atrial Fibrillation
Gregory Y.H. Lip, Cécile Laroche, Mircea Ioachim Popescu, Lars Hvilsted Rasmussen, Laura Vitali Serdoz, Gheorghe‐Andrei Dan, Zbigniew F. Kalarus, Harry J.G.M. Crijns, Mário Oliveira, Luigi Tavazzi et al. · 2015 · European Journal of Heart Failure
Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants
Margaret C. Fang, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, Niela K. Pomernacki, Natalia V. Udaltsova, Daniel E. Singer · 2012 · Stroke
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study
Laila Stærk, Emil Loldrup Fosbøl, Gregory Y.H. Lip, Morten Lamberts, Anders Nissen Bonde, Christian Tobias Torp-Pedersen, Brice Ozenne, Thomas Alexander Gerds, Gunnar Gislason, Jonas Bjerring Olesen · 2016 · European Heart Journal
Pre dicting D eterminants of A trial Fibrillation or Flutter for T herapy E lucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study
Javed M. Nasir, William C. Pomeroy, Adam T. Marler, Matthew C. Hann, Tina Baykaner, Ronald Jones, Richard Stoll, Katherine Hursey, Angela Meadows, Jennifer Walker et al. · 2017 · Heart Rhythm
Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
Inmaculada Hernandez, Yuting Zhang, Samir Saba · 2017 · The American Journal of Cardiology
Atrial Fibrillation in Older People: Concepts and Controversies
Zafraan Zathar, Anne Karunatilleke, Ameenathul M. Fawzy, Gregory Y.H. Lip · 2019 · Frontiers in Medicine
Dabigatran in real-world atrial fibrillation
Francisco Moscoso Costa, Jorge Ferreira, Miguel Mendes, João Carmo · 2016 · Thrombosis and Haemostasis
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Dominick Joseph Angiolillo, Shaun G. Goodman, Deepak L. Bhatt, John W. Eikelboom, Matthew J. Price, David J. Moliterno, Christopher Paul Cannon, Jean‐François Tanguay, Christopher Bull Granger, Laura Mauri et al. · 2016 · Circulation Cardiovascular Interventions
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015
Lars Jøran Kjerpeseth, Hanne Ellekjær, Randi Marie Selmer, Inger Ariansen, Kari Furu, Eva Skovlund · 2017 · European Journal of Clinical Pharmacology
How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?
Nicola J. Cooper, Jaime Peters, Monica C.W. Lai, Peter Jüni, Simon Wandel, Steve Palmer, Mike Paulden, Stefano Conti, Nicky J. Welton, Keith R. Abrams et al. · 2011 · Value in Health
Neurosurgical complications of direct thrombin inhibitors—catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran
Sarah T. Garber, Walavan Sivakumar, Richard H. Schmidt · 2012 · Journal of neurosurgery
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Berend Daan Westenbrink, Marco Alings, Christopher Bull Granger, John Hunter Alexander, Renato D. Lópes, Elaine M. Hylek, Laine Elliott Thomas, DANIEL M. WOJDYLA, Michael Hanna, Mátyás Keltai et al. · 2016 · American Heart Journal
Effects of dabigatran according to age in atrial fibrillation
Mandy N. Lauw, John W. Eikelboom, Michiel Coppens, Lars C. Wallentin, Salim Yusuf, Michael D. Ezekowitz, Jonas Oldgren, Juliet Nakamya, Jia Wang, Stuart J. Connolly · 2017 · Heart
Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective
Christopher X J Wong, Alex D. H. Brown, Hung‐Fat Tse, Christine M. Albert, Jonathan M. Kalman, Thomas Hugh Marwick, Dennis H. Lau, Prashanthan Sanders · 2017 · Heart Lung and Circulation
Atrial Fibrillation Detection Using a Novel Cardiac Ambulatory Monitor Based on Photo‐Plethysmography at the Wrist
A. Bonomi, Fons Schipper, Linda M. Eerikäinen, Jenny Margarito, Ralph van Dinther, Guido Muesch, Helma M. de Morree, Ronald M. Aarts, Saeed Babaeizadeh, David D. McManus et al. · 2018 · Journal of the American Heart Association
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial
Michela Brambatti, Harald Darius, Jonas Oldgren, Andreas Clemens, Herbert Noack, Martina Brueckmann, Salim Yusuf, Lars C. Wallentin, Michael D. Ezekowitz, Stuart J. Connolly et al. · 2015 · International Journal of Cardiology
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation
Yawen Deng, Fei Liu, Xiaolei Yang, Yunlong Xia · 2021 · Frontiers in Cardiovascular Medicine
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology · 2020 · Russian Journal of Cardiology
Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study
Hubert Cochet, Xavier Iriart, Soumaya Sridi, Claudia Camaioni, Olivier Corneloup, Michel Montaudon, François Laurent, Wieme Selmi, Pauline Renou, Zakaria Jalal et al. · 2018 · European Heart Journal - Cardiovascular Imaging
Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project
Banerjee, Amitava, Taillandier, Sophie, Olesen, Jonas Bjerring, Lane, Deirdre A., Lallemand, Benedicte, Lip, Gregory Y.H., Fauchier, Laurent · 2013 · International Journal of Cardiology
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Gregory Y.H. Lip, Thitima Kongnakorn, Hemant M. Phatak, Andreas Kuznik, Tereza Lanitis, Larry Z. Liu, Uchenna H. Iloeje, Luis G. Hernandez, Paul Dorian · 2014 · Clinical Therapeutics
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation
Yi‐Hsin Chan, Kun‐Chi Yen, Lai‐Chu See, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Hui‐Tzu Tu, Yung‐Hsin Yeh, Chi-Tai Kuo · 2016 · Stroke
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?
Nikolaos Dagres, Tze‐Fan Chao, Guilherme Fenelon, Luis Aguinaga, Daniel A. Benhayon, Emelia J. Benjamin, Thomas Jared Bunch, Lin Y. Chen, Shih‐Ann Chen, Francisco Darrieux et al. · 2018 · Journal of Arrhythmia
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis
Zardasht Oqab · 2018 · Journal of Atrial Fibrillation
Thrombo-Embolism and Antithrombotic Therapy for Heart Failure in Sinus Rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
Gregory Y.H. Lip, Piotr Ponikowski, Felicita Andreotti, Stefan D. Anker, Gerasimos Filippatos, Shunichi Homma, João Morais, Patrick M. Pullicino, Lars Hvilsted Rasmussen, Francisco R. Marín et al. · 2012 · European Journal of Heart Failure
Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population‐based cohort study
Anne Gulbech Ording, Erzsébet Horváth–Puhó, Kasper Adelborg, Lars Henning Pedersen, Paolo Prandoni, Henrik Toft Sørensen · 2017 · Cancer Medicine
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
Graeme J. Hankey, John W. Eikelboom · 2010 · The Lancet Neurology
Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation
Yugo Yamashita, Yasuhiro Hamatani, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Gregory Y.H. Lip, Masaharu Akao · 2015 · CHEST Journal
Atrial fibrillation in women: treatment
Darae Ko, Faisal Rahman, Maria Auxiliadora Parreiras Martins, Elaine M. Hylek, Patrick T. Ellinor, Renate B. Schnabel, Emelia J. Benjamin, Ingrid Elisabeth Christophersen · 2016 · Nature Reviews Cardiology
Risk factors for intracerebral hemorrhage in patients with COVID-19
Kara R. Melmed, Meng Cao, Siddhant Dogra, Ruina Zhang, Shadi R. Yaghi, Ariane K. Lewis, Rajan Jain, Seda Bilaloglu, Ji Chen, Barry M. Czeisler et al. · 2020 · Journal of Thrombosis and Thrombolysis
Left Atrial Volume Combined With Atrial Pump Function Identifies Hypertensive Patients With a History of Paroxysmal Atrial Fibrillation
Norihisa Toh, Hideaki Kanzaki, Satoshi Nakatani, Takahiro Ohara, Jiyoong Kim, KENGO FUKUSHIMA KUSANO, Kazuhiko Hashimura, Tohru Ohe, Hiroshi Ito, Masafumi Kitakaze · 2010 · Hypertension
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Amitava Banerjee, Laurent Fauchier, Patrick Vourc’h, Christian Robert Andres, Sophie Taillandier, Jean‐Michel Halimi, Gregory Y.H. Lip · 2013 · CHEST Journal
Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation
Nicole Lowres, Ines Krass, Lis Neubeck, Julie Redfern, Andrew J. McLachlan, Alexandra A Bennett, Ben Freedman · 2015 · International Journal of Clinical Pharmacy
Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
Sheldon M. Singh, Andrew Micieli, Harindra Channa Wijeysundera · 2013 · Circulation
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
William J. Canestaro, Amanda R. Patrick, Jerry Avorn, Kouta Ito, Olga S. Matlin, Troyen A. Brennan, William H. Shrank, Niteesh K. Choudhry · 2013 · Circulation Cardiovascular Quality and Outcomes
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Francisco R. Marín · 2017 · Thrombosis and Haemostasis
Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
AbdullahM Alshehri · 2019 · Journal of Family and Community Medicine
Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
Utibe R. Essien, Nadejda Kim, Leslie R. M. Hausmann, Maria K. Mor, Chester B. Good, Jared W. Magnani, Terrence M. A. Litam, Walid F. Gellad, Michael J. Fine · 2021 · JAMA Network Open
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC
George Ntaios, Helmut Baumgartner, Wolfram Doehner, Erwan Donal, Thor Edvardsen, Jeff S. Healey, Bernard Iung, Hooman Kamel, Scott Eric Kasner, Eleni Korompoki et al. · 2024 · European Heart Journal
One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010
Lisa Bergström, Anna-Lotta Irewall, Lars Söderström, Joachim Ögren, Katarina Laurell, Thomas Mooe · 2017 · Stroke
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
Ying Bai, Shi-Dong Guo, Hai Deng, Alena Shantsila, Laurent Fauchier, Changsheng Ma, Gregory Y.H. Lip · 2017 · Age and Ageing
Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review
Gemma Mas Dalmau, Elisenda Sant i Arderiu, María Enfedaque Montes, Iván Solà, Sandra Pequeño, Pablo Alonso‐Coello · 2017 · BMC Family Practice
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Irene Savelieva, A. John Camm · 2013 · Clinical Cardiology
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Mark J. Alberts, John W. Eikelboom, Graeme J. Hankey · 2012 · The Lancet Neurology
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data
Ramyashree Tummala, Ana Kavtaradze, Anjan Gupta, Raktim Kumar Ghosh · 2016 · International Journal of Cardiology
Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial
Derk L. Arts, Ameen Abu–Hanna, Stephanie K. Medlock, Henk C P M van Weert · 2017 · PLoS ONE
Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
Aurélien Delluc, Tzu‐Fei Wang, Eng Soo Yap, Cihan Ay, Jordan K. Schaefer, Marc Carrier, Simon Noble · 2019 · Journal of Thrombosis and Haemostasis
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal
María Asunción Esteve‐Pastor, Vanessa Roldán, José Miguel Rivera‐Caravaca, Inmaculada Ramírez-Macías, Gregory Y.H. Lip, Francisco R. Marín · 2019 · Thrombosis and Haemostasis
Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
Nicklas Vinter, Qiuxi Huang, Morten Fenger‐Grøn, Lars Frost, Emelia J. Benjamin, Ludovic Trinquart · 2020 · BMJ
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
Fareed Moses S. Collado, Claudia M. Lama von Buchwald, Christina K. Anderson, Nidhi Madan, Hussam S. Suradi, Henry D. Huang, Hani M. Jneid, Clifford J. Kavinsky · 2021 · Journal of the American Heart Association
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: Experience from the Stockholm health care system
Tomas Forslund, Björn Wettermark, Per Erik Wändell, Mia von Euler, Jan Hasselström, Paul Hjemdahl · 2013 · International Journal of Cardiology
Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Gregory Y.H. Lip · 2017 · PLoS ONE
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry
Yoshimori An, Hisashi Ogawa, Yugo Yamashita, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa et al. · 2018 · European Heart Journal - Quality of Care and Clinical Outcomes
Stroke Etiology and Thrombus Computed Tomography Characteristics in Patients With Acute Ischemic Stroke
Nikki Boodt, Kars C.J. Compagne, Bruna Garbugio Dutra, Noor Samuels, Manon L. Tolhuisen, Heitor Castelo Branco Rodrigues Alves, Manon Kappelhof, Geert J. Lycklama à Nijeholt, Henk A. Marquering, Charles B.L.M. Majoie et al. · 2020 · Stroke
Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists
Francesco Violi, Gregory Y.H. Lip, Pasquale Pignatelli, Daniele Pastori · 2016 · Medicine
Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials
Alpesh Amin, Steve Deitelzweig, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham · 2014 · Journal of Thrombosis and Thrombolysis
Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
José Ramón González‐Juanatey, José Álvarez‐Sabín, José María Lobos, Antoni Martínez‐Rubio, Joan Carles Reverter, Itziar Oyagüez, Núria González-Rojas, Virginia Becerra · 2012 · Revista Española de Cardiología
Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism
Christopher Bull Granger, Luciana Armaganijan · 2012 · Circulation
Cost-effectiveness of Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain
José Ramón González‐Juanatey, José Álvarez‐Sabín, José María Lobos, Antoni Martínez‐Rubio, Joan Carles Reverter, Itziar Oyagüez, Núria González-Rojas, Virginia Becerra · 2012 · Revista Española de Cardiología (English Edition)
Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis
Ziv Harel, Glenn Matthew Chertow, Prakesh S. Shah, Shai Harel, Paul Dorian, Andrew Tze-Kay Yan, Gustavo Saposnik, Manish M. Sood, Amber O. Molnar, Jeffrey M. Perl et al. · 2017 · Canadian Journal of Cardiology
Expert opinion paper on atrial fibrillation detection after ischemic stroke
Karl Georg Hæusler, Klaus Gröschel, Martin Köhrmann, Stefan D. Anker, Johannes Brachmann, Michael Böhm, Hans‐Christoph Diener, Wolfram Doehner, Matthias Endres, Christian P Gerloff et al. · 2018 · Clinical Research in Cardiology
Panel report: the dark side of the digitization of the individual
Ofir Turel, Christian Matt, Manuel Trenz, Christy M.K. Cheung, John D’Arcy, Hamed Qahri‐Saremi, Monideepa Tarafdar · 2019 · Internet Research
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
Koichi Kaikita, Kazuya Hosokawa, Jeffrey R. Dahlen, Kenichi Tsujita · 2019 · Thrombosis and Haemostasis
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial
David John Werring, Hakim‐Moulay Dehbi, Norin Ahmed, Elizabeth Arram, Jonathan G. Best, Maryam Balogun, Kate Bennett, Ekaterina Bordea, Emilia Caverly, Marisa Chau et al. · 2024 · The Lancet
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
Atul Verma, David H. Birnie, Chenyang Jiang, Hein Heidbüchel, Gerhard Hindricks, Paulus F. Kirchhof, Jeff S. Healey, Yunhe Wang, Nikolaos Dagres, Marc William Deyell et al. · 2025 · New England Journal of Medicine
Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation–Related Stroke
Derek Hayden, Niamh Hannon, Elizabeth L. Callaly, Danielle Ní Chróinín, Gillian Horgan, Lorraine Kyne, Joseph Duggan, Eamon Dolan, Killian O’Rourke, David James Williams et al. · 2015 · Stroke
Clinical Epidemiology of Atrial Fibrillation and Related Cerebrovascular Events in the United States
Kamakshi Lakshminarayan, David C. Anderson, Charles A. Herzog, Adnan Iqbal Qureshi · 2008 · The Neurologist
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Miklós Rohla, Thomas Werner Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta Maria Siller-Matula, Renate B. Schnabel, RICHARD JOHN SCHILLING, Dipak Kotecha, Markus Lucerna, Kurt Huber et al. · 2019 · BMJ Open
Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery
David Conen, Pablo Alonso‐Coello, James Demetrios Douketis, Matthew T.V. Chan, Andrea M. Kurz, Alben Sigamani, Joel L. Parlow, Chew Yin Wang, Juan Carlos Villar, Sadeesh Srinathan et al. · 2019 · European Heart Journal
Anticoagulants in atrial fibrillation patients with chronic kidney disease
Robert G. Hart, John W. Eikelboom, Alistair John Ingram, Charles A. Herzog · 2012 · Nature Reviews Nephrology
Novel Oral Anticoagulants in Atrial Fibrillation: A Meta‐analysis of Large, Randomized, Controlled Trials vs Warfarin
Ariel Dogliotti, Ernesto Paolasso, Robert Patrick Giugliano · 2013 · Clinical Cardiology